OFW logo
1-202-933-5394
MENU

Cannabis

DOJ Finalizes Move to Schedule III for Certain Marijuana Products

Cannabis /

The U.S. Department of Justice (DOJ), through the Drug Enforcement Administration (DEA), issued a final order partially rescheduling marijuana under federal law, effective April 22, 2026. While many headlines are framing this as “marijuana being moved to Schedule III,” the reality is more precise and limited—and reflects a phased approach closely tied to last year’s

DOJ Finalizes Move to Schedule III for Certain Marijuana Products Read More »

CANNASWEEP

Cannabis /

Lancet Psychiatry / STAT News: No Evidence Cannabis Is Effective for PTSD, Anxiety, or Depression — A landmark systematic review and meta-analysis published in The Lancet Psychiatry in March 2026 analyzed 54 randomized controlled trials covering the period 1980–2025 and found no evidence that cannabinoids are effective for anxiety, PTSD, depression, bipolar disorder, ADHD, or

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Study: Adolescent Cannabis Use Linked to Doubling Risk of Psychotic and Bipolar Disorders – A longitudinal cohort study of 463,396 adolescents ages 13–17, followed through age 26, found that past-year cannabis use during adolescence was associated with approximately twice the risk of developing psychotic or bipolar disorders. Study: Moderate Cannabis Use May Protect the Aging

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

January 2026 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about any of the items below, please contact us. We also track cannabis-related legislation introduced in the U.S. Congress.  If you would

CANNASWEEP Read More »

President Trump’s Executive Order (EO), “Increasing Medical Marijuana And Cannabidiol Research,” May Benefit The Cannabis Industry, But Alone, Does Not Reschedule Marijuana

Cannabis /

Today, President Trump signed an Executive Order (EO), Increasing Medical Marijuana and Cannabidiol Research.  While the EO is being widely hailed as a significant advancement in marijuana legalization, in fact, the EO is extremely limited as to marijuana and has no independent legal effect at all on rescheduling marijuana. The EO does represent a potentially

President Trump’s Executive Order (EO), “Increasing Medical Marijuana And Cannabidiol Research,” May Benefit The Cannabis Industry, But Alone, Does Not Reschedule Marijuana Read More »

CANNASWEEP

Cannabis /

Study: Inhaling Cannabis May Greatly Increase Your Risk of Lung Disease. The study found that inhaling marijuana every day is associated with a 44% increased chance of developing asthma. It also increases the odds of developing a common set of lung diseases known as chronic obstructive pulmonary disease (COPD) by 27%. Study: An experimental medication

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Research reveals vaping cannabinoid mixtures produces a chemical that destroys human tissue. Study: Using cannabis and psilocybin together may increase dependence. Study: cannabis users display brain network characteristics typically associated with younger brains, along with enhanced cognitive abilities, highlighting a potential modulatory role for cannabinoids and endocannabinoids in neurodegenerative processes, as explained through neural dedifferentiation

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

A study published in JAMA Neurology suggests that individuals who receive acute care for cannabis use may be at an increased risk for incident dementia compared to the general population. A new federally funded study determined that starting treatment with THC-dominant medicinal cannabis was linked to immediate reductions in anxiety and depression. A study on

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Compared with the general population or individuals who receive all-cause hospital-based care, those with acute care due to cannabis use may be at an increased risk for incident dementia, according to study results published in JAMA Neurology. Psychedelic substances, particularly when combined with behavioral therapies such as Motivational Enhancement Therapy (MET), show significant promise in

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

In a journal publication in Gastrointestinal Endoscopy, University of Oklahoma College of Medicine physician-researchers found that, during an endoscopy, cannabis users were 77% more likely to require higher doses of the anesthetic propofol compared to non-users, and 57% more likely to need higher doses of the sedative midazolam. In addition, diphenhydramine, an antihistamine often used for extra sedation, was

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

March 2025 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about any of the items below, please contact us. We also track cannabis-related legislation introduced in the U.S. Congress.  If you would

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Researchers at the George Washington University say a condition called cannabinoid hyperemesis syndrome occurs in people who are long-term regular consumers of cannabis and causes nausea, uncontrollable vomiting and excruciating pain in a cyclical pattern that often leads to repeated trips to the hospital. The use of medical cannabis products by qualified patients ages 50

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

January 2025 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about any of the items below, please contact us. We also track cannabis-related legislation introduced in the U.S. Congress. If

CANNASWEEP Read More »

CANNASWEEP

Cannabis, Uncategorized /

December 2024 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. Please contact us if you have any questions or want more information about any of the items below. We also track cannabis-related legislation introduced in the U.S. Congress. If you

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

November 2024 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about any of the items below, please contact us. We also track cannabis-related legislation introduced in the U.S. Congress.  If you would

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

The U.S. Supreme Court heard oral arguments in the case of a trucker who sued a cannabis company after he was fired over a positive THC test that he says was caused by consuming a hemp-derived CBD product. Report: The U.S. cannabis industry will need between $65.6B and $130.7B in sustainable growth capital to support new cannabis

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Weed Companies Are Making More Money Selling Beer Than Cannabis (Bloomberg) Barstool Sports announced its new partnership with multi-state cannabis operator Green Thumb Industries (GTI). Athletes, investors eye Fusion CBD Products as popularity of buying CBD online increases Schedule III Classification Offers New Opportunities For The Pre-Roll Industry 4 Reasons Why Cannabis Stocks Are a

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Home Depot, one of the largest employers in the United States, is shifting its employee drug testing policies to remove cannabis from screening panels entirely and stop pre-employment drug testing of most of its workers. Trulieve Cannabis Corp., a leading and top-performing cannabis company in the U.S., today announces a partnership with the Carvana PPA

CANNASWEEP Read More »

FDA and FTC Issue Warning Letters to Companies Selling Copycat Delta-8 THC Food Products

Cannabis, Uncategorized /

On July 16, 2024, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to six companies for illegally selling copycat food products containing delta-8 tetrahydrocannabinol (THC) and introducing them into the marketplace, violating the Federal Food, Drug, and Cosmetic (FD&C) Act. The FDA highlighted two primary concerns: the

FDA and FTC Issue Warning Letters to Companies Selling Copycat Delta-8 THC Food Products Read More »

CANNASWEEP

Cannabis /

WEEK OF JUNE 21, 2024 CannaSweep will be on hiatus given the Congressional recess and federal holiday. We will resume in August. OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Marijuana brand Stiiizy has triggered a public health crisis among teens by “marketing dangerous, high potency marijuana vaporizers” to youth, according to a lawsuit filed by an unidentified California high school student. Biden’s DEA Marijuana Scam: MMJ BioPharma Awaits Marijuana Registration to Grow Pharmaceutical Cannabis Curaleaf Holdings, Inc., a leading international provider of consumer products

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

How a Farm Bill amendment could ‘significantly impact’ hemp brands. Two West Coast police groups have changed their positions and now support federal cannabis legalization efforts, marking the first time that a statewide police officers organization has called for an end to the nation’s prohibition of marijuana. Cannabis producer Green Thumb Industries has expressed interest

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Organic Payment Gateways, a leading provider of alternative payment processing integrations, is excited to announce the launch of its new Authorize.Net payment gateway solutions tailored specifically for businesses in the CBD, nutritional supplement, and Farm Bill-compliant cannabis seed industries. Cannabis reclassification opens up new opportunities for software developers interested in tapping into this lucrative, but challenging, market. Reclassification of

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Can the boom in weed drinks last? (Morning Brew) Leafly Holdings, Inc. Reports First Quarter 2024 Financial Results – Reported net loss of $2.4 million and adjusted EBITDA1 loss of $0.9 million Tilray Brands Announces At-The-Market Program to Fund Strategic and Accretive Acquisitions and Accelerate Expansion Plan Upon U.S. Cannabis Rescheduling When Effective Top Marijuana

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Top public cannabis companies lost more than $2B in 2023 despite nearly $9B in revenue. Twenty of the largest publicly traded marijuana companies in the U.S. lost a cumulative $2.3 billion last year, and only one of them turned a profit. Adult-Use Cannabis Legalization States Surpass $20 Billion in Tax Revenue Cashing In on Cannabis:

CANNASWEEP Read More »

Cannabis Administration and Opportunity Act (CAOA) Reintroduced Following Rescheduling Announcement

Cannabis /

On May 1, 2024, Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR), and Senator Cory Booker (D-N.J.)  reintroduced the Cannabis Administration Opportunity Act (text available here). The reintroduction follows the news last week that the Drug Enforcement Administration (DEA) had begun the formal rulemaking process to move marijuana from Schedule I

Cannabis Administration and Opportunity Act (CAOA) Reintroduced Following Rescheduling Announcement Read More »

DEA Moving To Reschedule Marijuana?!

Cannabis /

Approved Human and Animal Drugs. FDA oversees and pre-approves the approval of pharmaceutical drugs derived from cannabis. Marijuana itself is not an FDA-approved drug. FDA has approved one cannabis-derived drug product, Epidiolex (CBD), and three synthetic cannabis-related drug products, Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). FDA has not approved a marketing application for any other

DEA Moving To Reschedule Marijuana?! Read More »

CANNASWEEP

Cannabis /

Report: Cannabis Industry Employs More Than 440,000 Full-time Workers. Cannabis Rolling Papers May Pose Health Risks From Heavy Metals, Study Finds (Forbes). Innocan Pharma Corporation announced on Monday that it has submitted its letter of application for a Pre-IND meeting with the FDA, for its Liposome-Cannabidiol (LPT-CBD) injectable treatment of chronic pain. With the move,

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Q&A: U.S. Hemp Authority President Chris Fontes – The industry group is creating a certification program for intoxicating hemp products, reflecting heightened concerns about the burgeoning market. (Politico) Organic Payment Gateways Announces a “Square Payment Processing Alternatives for CBD” Support Program – Reacting to increased interest from both retail and e-commerce CBD and hemp businesses, OrganicPaymentGateways.com has

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Publicly traded marijuana multistate operators exited regulated cannabis markets through late 2023, continuing a pattern fueled by increased capital costs, high taxes, and the slow pace of federal reform (This map pinpoints where the large MSOs are operating.) York views Flora Match, an AI-powered platform, as a game-changer in how cannabis products are selected and purchased,

CANNASWEEP Read More »

CANNASWEEP

Uncategorized, Cannabis /

The Big Problem for Marijuana Companies? What to Do With All That Cash. Few banks will work with cannabis upstarts—but some lawmakers hope to change that this year (The Wall Street Journal) OSHA Enforcement and Guidance on Protecting Workers within the Cannabis Industry – Webinar Series Medical Marijuana: New Court Ruling on Impairment at Work

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Handheld Marijuana Vaporizer Market Size to Hit USD 15.9 billion by 2031, Projected a 13.4% CAGR – Report by Transparency Market Research, Inc. Worker Advances Medical Cannabis Claim, Wrongful Discharge Nixed – A worker who lost her job at a scaffolding company after a positive drug test can move forward with allegations under a state

CANNASWEEP Read More »

CANNASWEEP

Cannabis /

Biden also tweeted during the SOTU, “No one should be jailed just for using or possessing marijuana.” Does Biden overpromise, underdeliver on marijuana reform? VP Harris to meet with marijuana pardon recipients at White House this week as Biden leans into issue ahead of election. USDA: USDA released its “Hemp Research Needs Roadmap,” which reflects

CANNASWEEP Read More »

CANNASWEEP 

Cannabis /

Options for buying a cannabis business in a dry capital market.  Other Noteworthy Updates   It’s 2024 And federal Law Still Does Not Protect Medical Marijuana Users From Getting Fired For Testing Positive (Mondaq).  Cannabis Tax Frenzy (Forbes).  Medical marijuana companies have stronger 280E argument: Former U.S. Justice Department’s Tax Division Official’s Opinion.  Navigating Hemp

CANNASWEEP  Read More »

Industries

Food & Agriculture
Medical Products
Customs and Trade
Consumer and Commercial Litigation
Government Relations

Our Firm

Home
People
Alumni
About
Contact

Insights

News & Insights
Blog
Facebook Twitter Linkedin